Blog Compliance Knowledge Base Manufacturing 
IBM Big Data Hub
JULY 19, 2023
Life sciences industry has—for decades now—moved from the traditional discovery-based drug development to target market-based drug development paradigm. Yet, it is burdened by long R&D cycles and labor-intensive clinical, manufacturing and compliancy regimens.
Data Matters
APRIL 23, 2021
Companies engaged in the development, manufacturing, importation, distribution, servicing, and use of AI – irrespective of industry – should assess to what extent their products are implicated and how they will address any regulatory requirements they are subject to. What are the Consequences of Non-Compliance? How is AI Defined?
Expert insights. Personalized for you.
66 
Let's personalize your content